We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$32.2B
AUM Growth
-$4.08B
Cap. Flow
-$2.36B
Cap. Flow %
-7.31%
Top 10 Hldgs %
28.98%
Holding
1,909
New
88
Increased
695
Reduced
604
Closed
32

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$322M
2
VZ icon
Verizon
VZ
+$156M
3
KO icon
Coca-Cola
KO
+$116M
4
V icon
Visa
V
+$114M
5
DIS icon
Walt Disney
DIS
+$92.1M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$475M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$276M
3
AAPL icon
Apple
AAPL
+$243M
4
TSLA icon
Tesla
TSLA
+$217M
5
MSFT icon
Microsoft
MSFT
+$209M

Sector Composition

Rank Sector Weight
1 Technology 31.24%
2 Healthcare 14.74%
3 Financials 14.38%
4 Communication Services 12.23%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1651
Recursion Pharmaceuticals
RXRX
$1.61B
$65K ﹤0.01%
12,307
ASND icon
1652
Ascendis Pharma A/S
ASND
$16.5B
$64K ﹤0.01%
411
EVH icon
1653
Evolent Health
EVH
$358M
$64K ﹤0.01%
6,741
JBI icon
1654
Janus International
JBI
$694M
$64K ﹤0.01%
8,867
QNST icon
1655
QuinStreet
QNST
$890M
$64K ﹤0.01%
3,562
SNDX icon
1656
Syndax Pharmaceuticals
SNDX
$1.73B
$64K ﹤0.01%
5,180
-1,774
-26% -$25K
UVV icon
1657
Universal Corp
UVV
$1.33B
$64K ﹤0.01%
1,141
AMPH icon
1658
Amphastar Pharmaceuticals
AMPH
$899M
$63K ﹤0.01%
2,159
RWT
1659
Redwood Trust
RWT
$585M
$63K ﹤0.01%
10,313
ADPT icon
1660
Adaptive Biotechnologies
ADPT
$3.85B
$62K ﹤0.01%
8,378
CABO icon
1661
Cable One
CABO
$224M
$62K ﹤0.01%
232
IART icon
1662
Integra LifeSciences
IART
$1.33B
$62K ﹤0.01%
2,839
NEO icon
1663
NeoGenomics
NEO
$2.04B
$62K ﹤0.01%
6,557
AMN icon
1664
AMN Healthcare
AMN
$1.35B
$61K ﹤0.01%
2,478
ARLO icon
1665
Arlo Technologies
ARLO
$1.57B
$61K ﹤0.01%
6,167
COUR icon
1666
Coursera
COUR
$1.51B
$61K ﹤0.01%
9,203
HRMY icon
1667
Harmony Biosciences
HRMY
$2.08B
$61K ﹤0.01%
1,844
IMVT icon
1668
Immunovant
IMVT
$8.11B
$61K ﹤0.01%
3,542
+443
+14% +$9.27K
TCBK icon
1669
TriCo Bancshares
TCBK
$1.85B
$61K ﹤0.01%
+1,532
New +$65.5K
VRE
1670
DELISTED
Veris Residential
VRE
$61K ﹤0.01%
3,600
EIG icon
1671
Employers Holdings
EIG
$941M
$60K ﹤0.01%
1,179
HLIT icon
1672
Harmonic Inc
HLIT
$1.22B
$60K ﹤0.01%
6,295
VRNT
1673
DELISTED
Verint Systems
VRNT
$60K ﹤0.01%
3,380
WWW icon
1674
Wolverine World Wide
WWW
$1.64B
$60K ﹤0.01%
4,303
AMR icon
1675
Alpha Metallurgical Resources
AMR
$1.82B
$59K ﹤0.01%
473

Similar funds

KBC Group's Q1 2025 Portfolio in Review

As of Q1 2025, KBC Group held 1,909 positions worth $32.2B, down 11% from $36.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

KBC Group withdrew a net $2.36B in Q1 2025, closing 32 positions and reducing 604 holdings. Its most notable exit was Aspen Technology Inc, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in Sandisk worth $2.93M.

  • KBC Group's largest Q1 2025 buy was Sandisk: 61,634 shares worth $2.93M.
  • KBC Group added most to Comcast in Q1 2025, an estimated $322M increase.
  • KBC Group's biggest Q1 2025 reduction was Amazon, cutting an estimated $475M.
  • KBC Group fully exited Aspen Technology Inc in Q1 2025, selling an estimated $10.3M.
  • KBC Group's ten largest holdings make up 29% of its $32.2B portfolio in Q1 2025.
  • KBC Group opened 88 new positions and closed 32 in Q1 2025.
  • KBC Group's portfolio value fell 11% quarter-over-quarter to $32.2B.

Based on KBC Group's 13F filing for Q1 2025, filed 25 Apr 2025.